Susanne Kollar

Learn More
OBJECTIVE Little is known about seizures in natalizumab-associated progressive multifocal leukoencephalopathy (NAT-PML). METHODS A review of clinical records of 15 NAT-PML patients with multiple sclerosis (MS) treated at a German university hospital. RESULTS Some 53% (8/15) of our patients developed seizures with often multiple semiologies (seven grand(More)
BACKGROUND AND PURPOSE The aim of this study was to elucidate the role of therapy-related cardiotoxicity in multiple sclerosis (MS) patients treated with mitoxantrone and to identify potential predictors for individual risk assessment. METHODS Within a multicenter retrospective cohort design, cardiac side effects attributed to mitoxantrone were analyzed(More)
  • 1